Press "Enter" to skip to content

Posts tagged as “pazopanib”

Phase 1b trial of docetaxel, prednisone, and pazopanib in men with metastatic castration-resistant prostate cancer. – UroToday

admin 0

Phase 1b trial of docetaxel, prednisone, and pazopanib in men with metastatic castration-resistant prostate cancer.  UroToday Docetaxel prednisone is a standard of care for men with metastatic castration-resistant prostate cancer (mCRPC),…